How NMN Is Made: From Lab Synthesis to Your Supplement

Why Manufacturing Matters for NMN

NMN is not a regulated pharmaceutical. In the dietary supplement market, there is no mandatory pre-market approval requiring proof of purity, potency, or identity before a product goes on sale. The result is significant variation in product quality across the market. A supplement label claiming "500 mg NMN" may contain that amount at high purity, or it may contain less NMN than stated, at lower purity, with byproducts from the synthesis process.

Understanding how NMN is made and what quality markers to look for is not just an academic exercise. It directly determines what enters your body. This article covers the synthesis routes, the raw material supply chain, what purity grades mean, and how to evaluate a Certificate of Analysis.

How NMN Is Synthesised: The Two Routes

Commercial NMN production uses two primary manufacturing approaches: enzymatic biosynthesis and chemical synthesis. The method matters for the quality of the end product.

Enzymatic Biosynthesis

Enzymatic biosynthesis uses biological systems, typically engineered bacteria (such as E. coli) or yeast strains that have been modified to express the NAMPT enzyme, to catalyse the conversion of nicotinamide and a phosphate donor into NMN. The enzymatic route mimics the natural biological pathway in mammalian cells and is highly selective: the enzyme only acts on the intended substrate in a specific way, producing fewer unwanted byproducts.

Advantages of enzymatic synthesis: high stereospecificity (producing only the biologically active beta-NMN form), cleaner product profile with fewer synthesis impurities, and better scalability for large batches. The downstream purification required is less extensive than for chemical routes, which contributes to higher purity at cost.

The majority of high-grade NMN raw material is produced using enzymatic or semi-enzymatic methods at scale in China and, increasingly, in Japan.

Chemical Synthesis

Multi-step chemical synthesis builds the NMN molecule from ribose derivatives and nicotinamide precursors through a series of organic chemistry reactions. The process typically involves phosphorylation of nicotinamide riboside or condensation of nicotinamide with a ribose-phosphate intermediate. Chemical synthesis routes are well-established in the pharmaceutical industry and can achieve high yields, but require more extensive downstream purification to remove synthesis byproducts and achieve pharmaceutical-grade purity.

Both routes can produce high-purity NMN. The key differentiator is not the route itself but the quality controls applied at each step and the rigour of the final analytical testing. A product produced by chemical synthesis with comprehensive third-party testing can be equal in quality to one produced enzymatically. The synthesis route tells you about the manufacturing process; the CoA tells you about the result.

The Raw Material Reality: China's Dominant Role

Approximately 84% of global NMN raw material originates from Chinese manufacturers. This is a structural feature of the global supplement market and is not unique to NMN: China is the world's largest producer of most supplement raw materials. The concentration is simply more pronounced for NMN due to the compound's relative novelty and the scale of Chinese fermentation and synthetic chemistry infrastructure.

This concentration creates two connected issues for buyers:

First, supply chain opacity. Many brands buy NMN raw material from Chinese manufacturers, encapsulate or powder it domestically, apply their label, and sell it as a "US-made" product. The raw material itself, its synthesis conditions, and its initial quality control happen outside the US regulatory framework. Without third-party testing of the final product, the buyer cannot know whether the raw material meets the purity claimed.

Second, quality variation. Chinese NMN manufacturing ranges from GMP-compliant pharmaceutical-grade facilities to much lower-standard operations. The same API (active pharmaceutical ingredient) name covers a wide range of actual product quality. Purity differences of 10 to 20 percentage points between nominally identical products from different Chinese manufacturers are documented in the industry.

What NMN Purity Percentage Actually Means

Purity is expressed as a percentage of the measured material that is the target compound (NMN) versus other substances. At 98% purity, 98% of the mass is NMN and up to 2% may be impurities, degradation products, residual solvents, moisture, or chemically related compounds from the synthesis process.

The 98% threshold is the industry benchmark for pharmaceutical-grade NMN. Products below 90% purity contain significant amounts of non-NMN material. This matters because synthesis byproducts are not biologically neutral: depending on their identity, they may be benign (related nicotinamide metabolites), mildly undesirable (solvent residues), or actively problematic.

Purity is measured by High Performance Liquid Chromatography (HPLC), which separates the components of a sample and quantifies each peak. An HPLC chromatogram in a CoA shows whether the sample is predominantly NMN (one large peak at the correct retention time) or contains significant other material (multiple peaks of comparable size).

Third-Party Testing: What It Is and Why It Matters

Third-party testing means the product's purity and composition have been tested by a laboratory that is independent of the manufacturer and has no commercial interest in the result. This independence is what makes it meaningful. Manufacturer-conducted testing has an inherent conflict of interest: the company testing its own product has financial incentive to report good results. An independent lab has no such incentive.

For NMN specifically, third-party testing addresses three key concerns:

Identity verification: Confirms the product actually contains NMN and not a cheaper related compound or a diluted mixture. Some low-quality products contain nicotinamide riboside (NR) mislabelled as NMN, or a mixture of the two.

Purity confirmation: Measures the actual NMN content by HPLC and reports the percentage. This is the only way to confirm the label claim.

Contaminant screening: Tests for heavy metals (lead, mercury, arsenic, cadmium), microbiological contamination, and residual solvents from the manufacturing process.

A Certificate of Analysis from a third-party lab is the documentary output of this testing. Without it, a purity claim on a label is unverifiable.

Reading a Certificate of Analysis

A CoA for NMN should contain the following elements to be considered meaningful:

Laboratory identification: The name and contact details of the testing laboratory. It must be an independent, accredited facility, not an in-house lab at the manufacturer. Look for ISO 17025 accreditation or equivalent.

Batch number and date: Ties the CoA to a specific production batch. A single historical CoA applied to ongoing production is not current verification. Each batch should have its own testing documentation.

NMN purity by HPLC: The percentage of NMN measured in the sample with the method stated. A result below 98% should prompt scrutiny.

Moisture content: NMN is hygroscopic and gains weight as it absorbs moisture. High moisture content means you are paying for water rather than active compound. A low moisture reading confirms proper handling and storage.

Heavy metals: Should include results for lead, mercury, arsenic, and cadmium with limits specified.

Microbiological screen: Total plate count, yeast and mould, and absence of pathogens such as Salmonella and E. coli.

GMP Manufacturing and FDA-Regulated Facilities

GMP (Good Manufacturing Practice) is a set of minimum quality standards governing the manufacturing of dietary supplements. In the United States, the relevant regulation is 21 CFR Part 111, enforced by the FDA. GMP requirements cover facility cleanliness, equipment maintenance, personnel training, quality control procedures, batch record keeping, and product testing.

GMP certification does not guarantee a specific purity level. A GMP-certified facility can produce low-purity NMN if the raw material it uses is low purity. GMP governs the process environment and documentation standards, not the quality of the raw material input. This is why GMP certification and third-party CoA testing are complementary quality markers, not substitutes for each other.

For Solensis NMN Powder: the product is manufactured in the USA in a GMP-certified, FDA-regulated facility and independently tested by Adamson Analytical Laboratories (Corona, CA 92879) for purity, identity, and safety. The Certificate of Analysis is available on request.

Frequently Asked Questions

How is NMN made?

NMN is produced commercially through two main routes: enzymatic biosynthesis using engineered bacterial or yeast cells that express the NAMPT enzyme to convert nicotinamide into NMN, and multi-step chemical synthesis starting from ribose derivatives and nicotinamide precursors. Enzymatic biosynthesis is preferred at scale because it produces fewer chemical byproducts and is more selective, resulting in higher purity output with less extensive downstream purification.

Where is most NMN raw material produced?

The majority of NMN raw material is produced in China, which supplies the bulk of the global supplement market. This concentration creates supply chain variability in manufacturing standards. NMN products sold in the US and Europe frequently use Chinese raw material even when the final product is encapsulated or labelled domestically. Third-party testing by an independent US or EU laboratory is the most reliable way to verify the quality of the final product regardless of raw material origin.

What does NMN purity percentage mean?

Purity percentage refers to the proportion of the material that is actually NMN versus other compounds. At 98% purity, 98% of the measured material is NMN and up to 2% may be impurities, degradation products, or related compounds. Pharmaceutical-grade NMN should be at least 98% pure. Products below this threshold contain more synthesis byproducts or moisture, reducing the effective dose per gram.

What is a Certificate of Analysis for NMN?

A Certificate of Analysis (CoA) is a document from an analytical laboratory reporting the measured composition and quality of a specific batch. For NMN, a CoA from an independent third-party laboratory should show: NMN purity by HPLC, moisture content, heavy metal results, microbiological contamination results, and batch identification. A CoA from the manufacturer's own lab is not independent verification; the lab must be named, accredited, and independent of the brand.

What is GMP certification for NMN supplements?

GMP (Good Manufacturing Practice) governs how supplements are manufactured, tested, and packaged under FDA-regulated conditions (21 CFR Part 111 in the US). GMP certification does not guarantee a specific purity level but means the manufacturing environment is controlled and audited. GMP and third-party CoA testing are complementary markers: GMP covers process quality; the CoA covers the actual product composition.

Is third-party tested NMN better?

Yes. Third-party testing by an independent, named, accredited laboratory is the only way to verify that a supplement contains what it claims at the stated purity. Manufacturer testing has an inherent conflict of interest. For NMN specifically, where raw material quality can vary significantly between suppliers, independent third-party CoA documentation from a named US or EU laboratory is a meaningful quality differentiator.

What is the difference between enzymatic and chemical NMN synthesis?

Enzymatic biosynthesis uses biological catalysts to convert nicotinamide into NMN with high selectivity and fewer unwanted byproducts. Chemical synthesis uses organic chemistry reactions but requires more extensive purification to remove synthesis byproducts. Enzymatic synthesis tends to produce higher purity NMN at equivalent scale. Both routes can achieve pharmaceutical-grade purity with appropriate quality controls; the CoA result is what confirms the outcome regardless of method.